Literature DB >> 26045226

Extent of lymphadenectomy to associate with pancreaticoduodenectomy in patients with pancreatic head cancer for better tumor staging.

Sergio Pedrazzoli1.   

Abstract

OBJECTIVES: To define the extent of lymphadenectomy to associate with surgery for pancreatic head cancer.
BACKGROUND: Pancreaticoduodenectomy with extended lymphadenectomy fails to prolong patient survival.
METHODS: Prospective randomized and nonrandomized controlled trials (RCTs and NRCTs), meta-analyses, retrospective reviews, consensus conferences and pre- and intraoperative diagnoses of lymph node (LN) metastases were retrieved. Standard and extended lymphadenectomies were reviewed, including their effects on postoperative complications, mortality rate and long-term survival. The minimum total number of LN examined (TNLE) for adequate tumor staging, and the incidence of metastasis to each LN station were also considered. A pros and cons analysis was performed on the removal of each LN station.
RESULTS: Eleven retrospective studies (2514 patients), five prospective NRCTs (545 patients), and five prospective RCTs (586 patients) described different lymphadenectomies, which obtained similar long-term results. Five meta-analyses showed they did not influence long-term survival. However, N status is an important component of tumor staging. The recommended minimum TNLE is 15. The percent incidence of metastasis to each LN station was calculated considering at least 385 and up to 3725 patients. Preoperative imaging and intraoperative exploration frequently fail to identify metastatic nodes. A pros and cons analysis suggests that lymph node status is better established removing the following LN stations: 6, 8a-p, 12a-b-c, 13a-b, 14a-b-c-d, 16b1, 17a-b. Metastasis to 16b1 LNs significantly worsens prognosis. Their removal and frozen section examination, before proceeding with resection, may contraindicate resection.
CONCLUSION: A standard lymphadenectomy demands an adequate TNLE and removal of the LN stations metastasizing more frequently, without increasing the surgical risk.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lymphadenectomy; Pancreatic cancer; Pancreatic surgery; Pancreaticoduodenectomy

Mesh:

Year:  2015        PMID: 26045226     DOI: 10.1016/j.ctrv.2015.04.013

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  9 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

2.  Para-Aortic Dissection in Pancreaticoduodenectomy with Mesopancreas Excision for Pancreatic Head Carcinoma: Not Only an N-Staging Matter.

Authors:  Nadia Peparini
Journal:  J Gastrointest Surg       Date:  2016-03-21       Impact factor: 3.452

3.  A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer.

Authors:  Toshiro Masuda; Amanda M Dann; Irmina A Elliott; Hideo Baba; Stephen Kim; Alireza Sedarat; V Raman Muthusamy; Mark D Girgis; O Joe Hines; Howard A Reber; Timothy R Donahue
Journal:  J Gastrointest Surg       Date:  2017-10-17       Impact factor: 3.452

4.  Increased pancreatic cancer survival with greater lymph node retrieval in the National Cancer Data Base.

Authors:  Carlo M Contreras; Chee Paul Lin; Robert A Oster; Sushanth Reddy; Thomas Wang; Selwyn Vickers; Martin Heslin
Journal:  Am J Surg       Date:  2017-07-01       Impact factor: 2.565

5.  The Role of CT in Assessment of Extraregional Lymph Node Involvement in Pancreatic and Periampullary Cancer: A Diagnostic Accuracy Study.

Authors:  Dorine S J Tseng; Bobby K Pranger; Maarten S van Leeuwen; Jan Pieter Pennings; Lodewijk A Brosens; Nadja Haj Mohammad; Vincent E de Meijer; Hjalmar C van Santvoort; Joris I Erdmann; I Quintus Molenaar
Journal:  Radiol Imaging Cancer       Date:  2021-03-19

6.  Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.

Authors:  Cosimo Sperti; Mario Gruppo; Stella Blandamura; Michele Valmasoni; Gioia Pozza; Nicola Passuello; Valentina Beltrame; Lucia Moletta
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

7.  Extended versus peripancreatic lymph node dissection for the treatment of left-sided pancreatic cancer.

Authors:  Huisong Lee; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi
Journal:  Ann Surg Treat Res       Date:  2017-05-29       Impact factor: 1.859

Review 8.  An update on treatment options for pancreatic adenocarcinoma.

Authors:  Aurélien Lambert; Lilian Schwarz; Ivan Borbath; Aline Henry; Jean-Luc Van Laethem; David Malka; Michel Ducreux; Thierry Conroy
Journal:  Ther Adv Med Oncol       Date:  2019-09-25       Impact factor: 8.168

Review 9.  [Definition and treatment of superior mesenteric artery revascularization and dissection-associated diarrhea (SMARD syndrome) in Germany].

Authors:  Patrick Téoule; Katharina Tombers; Mohammad Rahbari; Flavius Sandra-Petrescu; Michael Keese; Nuh N Rahbari; Christoph Reißfelder; Felix Rückert
Journal:  Chirurg       Date:  2021-06-08       Impact factor: 0.955

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.